Epstein Secrets

no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben

ashing ethical standards — of both formal and common sense varieties — before he was ever charged with a crime. A year before Collins was indicted, the Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Au

no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben

ashing ethical standards — of both formal and common sense varieties — before he was ever charged with a crime. A year before Collins was indicted, the Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Au

no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben

ashing ethical standards — of both formal and common sense varieties — before he was ever charged with a crime. A year before Collins was indicted, the Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Au